Hong Kong-Based Pharma Aptorum Seeks To Raise Up To $30M In US IPO

Login to View

Hong Kong-based pharmaceutical company Aptorum Group Limited is seeking to raise up to US$30 million in an initial public offering of its class A ordinary shares in the U.S., according to a statement released by the company yesterday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Read 3 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription for $359

Enjoy comprehensive and exclusive data you can't find elsewhere!

Subscribe for $359

Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in